{
    "clinical_study": {
        "@rank": "151441", 
        "arm_group": [
            {
                "arm_group_label": "control", 
                "description": "Patients with growth of S. aureus from sterile site cultures between Sept 15, 2012 - Dec 31, 2012.  No rapid testing was performed, and standard bacterial culture and susceptibility testing was done."
            }, 
            {
                "arm_group_label": "intervention", 
                "description": "Patients with growth of S. aureus from sterile site cultures between Sept 15, 2013 - Dec 31, 2013.  Rapid PBP2a testing was performed along with pharmacist notification of service if modification to therapy needed based on rapid test results."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the impact of the Alere&#8482; PBP2a test\n      combined with pharmacist review of antimicrobial therapy, on clinical outcomes and cost in\n      hospitalized patients with sterile site S. aureus infection."
        }, 
        "brief_title": "Impact of Rapid Detection of MRSA", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Staphylococcus Aureus Infections", 
        "condition_browse": {
            "mesh_term": "Staphylococcal Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. Inpatients (adults and children) at Mayo Clinic, Rochester with sterile source S.\n             aureus cultures (both control and intervention periods)\n\n          2. Above, with rapid PBP2a testing (intervention period only).\n\n        Exclusion criteria:\n\n          1. Patients with polymicrobial cultures (i.e., growth of S. aureus plus other organisms\n             in the culture).\n\n          2. Patients who have not provided MN authorization to use their medical records for\n             research.\n\n          3. Patients who have had the FilmArray Blood culture identification diagnostic test\n             performed on an index S. aureus blood culture.\n\n          4. Patients who have had a sterile source S. aureus culture within the prior 30 days."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Inpatients (adults and children) at Mayo Clinic, Rochester with sterile source S. aureus\n        cultures between Sept 15, 2012 - Dec 31, 2012 (control) and Sept 15, 2013 - Dec 31, 2013\n        (intervention)"
            }
        }, 
        "enrollment": {
            "#text": "240", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02027389", 
            "org_study_id": "13-008045"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "MSSA, MRSA", 
        "lastchanged_date": "January 2, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Clinical and Economic Impact of a Rapid Test for Detection of Methicillin-resistant Staphylococcus Aureus (MRSA) From Sterile Sites (the Alere&#8482; PBP2a)", 
        "other_outcome": [
            {
                "measure": "Proportion of patients with MSSA infection who are switched from an MRSA-active drug to an MSSA-active drug .", 
                "safety_issue": "No", 
                "time_frame": "within 48 hours of Gram-stain result"
            }, 
            {
                "measure": "Duration of bacteremia in patients with MSSA or MRSA bloodstream infections", 
                "safety_issue": "No", 
                "time_frame": "within first 30 days of culture result"
            }, 
            {
                "measure": "Time to contact isolation in patients with MRSA infections", 
                "safety_issue": "No", 
                "time_frame": "within first 7 days of culture result"
            }, 
            {
                "measure": "Length of hospitalization", 
                "safety_issue": "No", 
                "time_frame": "from time of culture result to hospital discharge, an expected average duration of 4 weeks"
            }, 
            {
                "description": "participants will be followed for the duration of hospital stay following positive culture result, an expected average of 4 weeks.", 
                "measure": "Total healthcare costs (broken down by bed, laboratory, and pharmacy costs).", 
                "safety_issue": "No", 
                "time_frame": "from time of culture result to time of hospital discharge, an expected average duration of 4 weeks"
            }, 
            {
                "measure": "Proportion of patients where a electronic (P-care) rule flagged for discordant therapy for the PBP2a result", 
                "safety_issue": "No", 
                "time_frame": "within first 3 days after culture result"
            }, 
            {
                "measure": "Proportion of patients where the pharmacist contacted the service to modify therapy", 
                "safety_issue": "No", 
                "time_frame": "wihtin first 7 days after culture result"
            }
        ], 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Ritu Banerjee, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Time (hours) to optimal antimicrobial therapy for patients with MSSA and MRSA infections in the pre-intervention and post-intervention periods", 
            "safety_issue": "No", 
            "time_frame": "within first 7 days of culture result"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02027389"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Ritu Banerjee, M.D., Ph.D.", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time (in hours) to identification of MRSA.", 
                "safety_issue": "No", 
                "time_frame": "within first 3 days of culture result"
            }, 
            {
                "measure": "Vancomycin days of therapy following S. aureus culture result", 
                "safety_issue": "No", 
                "time_frame": "during the 2 weeks following culture result"
            }
        ], 
        "source": "Mayo Clinic", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "January 2014"
    }
}